Analysis of EVs of TKI-resistant cancer cells as well as plasma of patients with TKI-resistant metastatic cancer reveal an enrichment in SLC1A5 and SLC25A5 solute carrier transporters and ALDHA1. The gene discussed is SLC1A5; the disease is metastatic malignant neoplasm.